STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PLX PROTALIX BIOTHERAPEUTICS INCORPORATED StockScouter® Report

7

StockScouter® Score

PROTALIX BIOTHERAPEUTICS INCORPORATED, a micro cap value company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The multi-period measure of relative price change and consistency is well above average. Positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

D
C
C
A

Previous Ratings

5
7
5